The order was checked at entry and again at pharmacy review — but it typically isn’t re-checked at the cabinet, against the patient as they are now. Safer-Med is that missing check: a real-time safety net at the automated dispensing cabinet that re-checks every dispense and override against the patient’s live picture, catches an approved order that turned unsafe and an override that doesn’t fit the patient, and routes it to the nurse in time to review — before it reaches the patient.
Designed to support Joint Commission 2026 medication-management priorities · read-only to the EMR · fully reversible
Why it matters for health systems
Real-time, patient-specific review at the cabinet, designed to support Joint Commission’s 2026 medication-management priorities (NPG #14, Effectively Managing Medications), including anticoagulant safety — where lab-conditioned risk is highest.
AI can help prioritize which overrides to review first, instead of reading free-text justifications across the board weeks after the fact. A selection not flagged is not a safety clearance and does not remove any required override review — the AI does not certify the rest as appropriate or replace pharmacy governance. Returned pharmacist time is a pilot objective to measure, not a guarantee.
Every alert and its signed acknowledgment — held or proceeding — captured as a verifiable record for medication-safety governance and quality reporting.
Safer-Med does not replace prescriber order entry, does not modify your cabinets, and never writes back to the EMR. Turning it off changes nothing in your existing workflow.
New here? Start with what Safer-Med does and the systemic gap it closes on the main page.
Questions we get
No. Medication errors are systemic failures, so Safer-Med is a systematic safeguard — not more noise. It fires only when something genuinely warrants it: a risk that is new since pharmacy last reviewed the order, or an override that skipped review entirely — and lab-driven alerts must be corroborated by a recent value, so the one alert that matters isn’t buried. It’s engineered against alert fatigue, not adding to it.
No. Safer-Med is read-only to the EMR and never writes back — no orders, no chart entries. Its output is an alert to a clinician, not an order.
No hardware or firmware change. Safer-Med rides the standard dispense and override events your cabinets already emit; it never locks a drawer or blocks a dispense — it surfaces the finding and asks the nurse to review, in time to act.
It’s engineered against it. A dispense alert fires only when the risk is new since pharmacy last reviewed the order, and lab-driven alerts require a recent corroborating value. You can run everything in silent mode first — per unit and per audience — and measure the volume before a nurse is ever paged.
Safer-Med runs in a single-tenant, isolated AWS environment dedicated to your organization — or on-premise where your infrastructure supports it — encrypted in transit and at rest, and HITRUST-aligned. The AI runs under a signed Business Associate Agreement; no PHI leaves the environment until it is in place.
It uses industry-standard interfaces — HL7 and FHIR for the EMR, standard feeds for the cabinets and your communications platform. Most of the work is a single channel build; hands-on interface work is an estimated 15–20 hours based on comparable integrations. Data extraction, security approval, clinical governance and education are scoped separately, phase by phase. See the technical brief for informatics.
Yes — fully reversible. Safer-Med is a separate component; turning it off has no effect on your EMR or cabinet workflow. Live alerting activates gradually, unit by unit, and only when you choose.
Development partners
AI-enabled medication safety is arriving fast, and the health systems that shape it now will set the standard the rest of the field follows. As a development partner, your pharmacy team helps define how Safer-Med works — tuned to your workflows, clinical behaviors, and priorities — putting your organization at the forefront of a real-time safety category that supports Joint Commission’s 2026 medication-management priorities, including anticoagulant safety and override governance.
The first step is low-risk and concrete: a retrospective on your historical data, under BAA — we show your medication-safety leaders what Safer-Med would have surfaced over the prior year, before a single live alert. It is a chance to bring high-value innovation into your organization, with clear objectives to measure in a pilot: fewer preventable adverse drug events, pharmacist review focused where risk is highest, and a survey-ready safety story.
We’re seeking one or two health-system development partners. If your organization wants to lead in patient-safety innovation, let’s talk.
The first step is a joint pharmacy & nursing workshop to scope a retrospective on your own data — it sets scope, responsibilities and decision criteria, with no commitment to later phases.
It takes two champions. Safer-Med reaches the nurse holding the dose, so nursing leadership is a co-decision-maker on any rollout. See the view for nursing leadership →
Tell us about your cabinets, your override governance, and your medication-safety priorities — we’ll show you what Safer-Med would surface on your own data.